NORGES BANK - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 251 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2024$7,562,724
-17.0%
942,983
-15.8%
0.00%
-50.0%
Q4 2023$9,109,315
+15.5%
1,120,4570.0%0.00%0.0%
Q2 2023$7,888,017
-47.1%
1,120,457
-54.1%
0.00%
-33.3%
Q1 2023$14,908,748
-21.6%
2,440,057
-18.0%
0.00%
-40.0%
Q4 2022$19,009,336
+42.1%
2,974,857
+113.0%
0.01%
+25.0%
Q3 2022$13,377,100
-10.5%
1,396,357
+3.1%
0.00%0.0%
Q2 2022$14,950,754
-33.7%
1,354,235
+0.0%
0.00%
-20.0%
Q1 2022$22,539,754
-9.3%
1,353,739
+4.0%
0.01%0.0%
Q4 2021$24,845,000
-18.6%
1,301,450
+5.1%
0.01%
-28.6%
Q3 2021$30,534,000
-1.0%
1,238,198
+4.4%
0.01%0.0%
Q2 2021$30,851,000
-20.4%
1,185,673
-3.2%
0.01%
-22.2%
Q1 2021$38,765,000
-43.3%
1,224,416
-16.9%
0.01%
-43.8%
Q4 2020$68,330,000
+35.6%
1,472,631
-3.8%
0.02%
+23.1%
Q3 2020$50,373,000
+26.6%
1,530,154
+5.5%
0.01%
+18.2%
Q2 2020$39,796,000
+1.6%
1,449,779
+10.8%
0.01%
-21.4%
Q1 2020$39,184,000
+8.1%
1,308,9790.0%0.01%
+40.0%
Q4 2019$36,233,000
+227.8%
1,308,979
+115.5%
0.01%
+233.3%
Q3 2019$11,055,000
+2156.1%
607,429
+2937.1%
0.00%
Q2 2019$490,000
+157.9%
20,0000.0%0.00%
Q1 2019$190,000
+7.3%
20,0000.0%0.00%
Q4 2018$177,00020,0000.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,019,201$26,720,00020.38%
Broadfin Capital, LLC 5,951,153$52,668,0006.92%
GREAT POINT PARTNERS LLC 5,567,348$49,271,0006.23%
Avoro Capital Advisors LLC 10,261,039$90,810,0005.43%
FRAZIER MANAGEMENT LLC 2,188,331$19,367,0005.00%
Prosight Management, LP 1,062,500$9,403,0004.85%
Perceptive Advisors 12,241,111$108,333,0004.12%
Ghost Tree Capital, LLC 1,000,000$8,850,0003.21%
QVT Financial LP 1,021,361$8,696,0002.84%
Vivo Capital, LLC 1,600,000$14,160,0001.81%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders